STRENSIQ 18 mg/.45mL (Asfotase Alfa SOLUTION) 18 mg/.45mL

STRENSIQ 18 mg/0.45mL is a subcutaneous solution containing asfotase alfa, used for enzyme replacement therapy. This medication is designed to address specific metabolic conditions by replacing deficient enzymes.

Strength

18 mg/.45mL

Pack Size

12 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01)

Manufacturer / TM Owner

Alexion Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

STRENSIQ is primarily used in enzyme replacement therapy to manage conditions caused by enzyme deficiencies. It is often prescribed for patients who lack certain enzymes necessary for normal metabolic function. The medication works by providing the missing enzyme, helping to alleviate symptoms associated with these deficiencies.

Side Effects

Common effects of STRENSIQ may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience fatigue or mild gastrointestinal discomfort. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

STRENSIQ should be handled with care, following the instructions provided by the healthcare provider. It is important to store the medication properly and to use sterile techniques when administering the subcutaneous injections. Patients should be monitored for any signs of allergic reactions or other adverse effects.

Avoid Interactions

STRENSIQ may interact with other medications or substances, so it is important to inform your healthcare provider about all the medications you are taking. Alcohol and certain other substances may affect the efficacy or safety of STRENSIQ, so it is advisable to avoid them unless directed otherwise by a healthcare professional.

References

Frequently Asked Questions

STRENSIQ is used for enzyme replacement therapy to manage conditions caused by enzyme deficiencies.

STRENSIQ is administered subcutaneously, typically through injections.

Common side effects may include reactions at the injection site, fatigue, and mild gastrointestinal discomfort.

It is important to consult with a healthcare provider before using STRENSIQ with other medications to avoid potential interactions.

STRENSIQ should be stored according to the instructions provided by the healthcare provider, typically in a cool, dry place.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.